TC
Tejara Capital Portfolio holdings
AUM
$216M
This Quarter Return
+7.71%
1 Year Return
-14.3%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$239M
AUM Growth
+$239M
(+36%)
Cap. Flow
+$52.1M
Cap. Flow
% of AUM
21.8%
Top 10 Holdings %
Top 10 Hldgs %
47.13%
Holding
79
New
15
Increased
27
Reduced
17
Closed
11
Top Buys
| 1 |
Roivant Sciences
ROIV
|
$19.9M |
| 2 |
Newmont
NEM
|
$9.57M |
| 3 |
Liberty Global Class A
LBTYA
|
$9.41M |
| 4 |
Nabors Industries
NBR
|
$6.45M |
| 5 |
Heron Therapeutics
HRTX
|
$5.38M |
Top Sells
| 1 |
Citigroup
C
|
$15.6M |
| 2 |
Cameco
CCJ
|
$7.57M |
| 3 |
Peabody Energy
BTU
|
$4.84M |
| 4 |
Collegium Pharmaceutical
COLL
|
$4.58M |
| 5 |
CNR
Core Natural Resources, Inc.
CNR
|
$3.31M |
Sector Composition
| 1 | Healthcare | 38.1% |
| 2 | Energy | 31.79% |
| 3 | Materials | 9.47% |
| 4 | Financials | 6.54% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
VanEck Junior Gold Miners ETF
GDXJ
$6.6B
| $2.92M | 1.22% | +76,900 | New | +$2.92M |
|
27
Ardmore Shipping
ASC
$473M
| $2.73M | 1.14% | 193,894 +103,894 | +115% | +$1.46M |
|
28
Zymeworks
ZYME
$1.12B
| $2.66M | 1.11% | 255,575 -32,518 | -11% | -$338K |
|
29
Mativ Holdings
MATV
$687M
| $2.49M | 1.04% | 162,515 -2,590 | -2% | -$39.7K |
|
30
Sociedad Química y Minera de Chile
SQM
$13B
| $2.35M | 0.98% | 39,000 +24,000 | +160% | +$1.45M |
|
|
CNR
31
Core Natural Resources, Inc.
CNR
$3.82B
| $2.19M | 0.92% | 21,831 -32,924 | -60% | -$3.31M |
|
32
Kenvue
KVUE
$39.7B
| $2.05M | 0.86% | 95,000 -30,000 | -24% | -$646K |
|
33
NexGen Energy
NXE
$4.5B
| $2.01M | 0.84% | +287,800 | New | +$2.01M |
|
34
Oportun Financial
OPRT
$291M
| $1.82M | 0.76% | 466,320 -36,331 | -7% | -$142K |
|
35
Telesat
TSAT
$307M
| $1.75M | 0.74% | 168,235 +28,264 | +20% | +$295K |
|
36
Denison Mines
DNN
$2.08B
| $1.72M | 0.72% | 971,658 +340,400 | +54% | +$603K |
|
37
Trevi Therapeutics
TRVI
$883M
| $1.7M | 0.71% | 1,269,000 +1,088,773 | +604% | +$1.46M |
|
38
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $1.67M | 0.7% | 95,149 +60,149 | +172% | +$1.06M |
|
39
The Mosaic Company
MOS
$10.6B
| $1.56M | 0.65% | 43,745 -5,000 | -10% | -$179K |
|
|
ICD
40
DELISTED
Independence Contract Drilling, Inc.
ICD
| $1.31M | 0.55% | 534,944 +95,000 | +22% | +$233K |
|
41
ANI Pharmaceuticals
ANIP
$2.03B
| $1.27M | 0.53% | +23,000 | New | +$1.27M |
|
42
International Seaways
INSW
$2.24B
| $1.23M | 0.51% | +27,000 | New | +$1.23M |
|
43
Stratasys
SSYS
$906M
| $1.13M | 0.47% | +79,315 | New | +$1.13M |
|
44
Agnico Eagle Mines
AEM
$72.4B
| $1.12M | 0.47% | +20,500 | New | +$1.12M |
|
45
AGNC Investment
AGNC
$10.2B
| $1.09M | 0.46% | 110,880 -238,564 | -68% | -$2.34M |
|
46
Sutro Biopharma
STRO
$72.7M
| $974K | 0.41% | 226,953 +138,271 | +156% | +$593K |
|
|
CRDL
47
Cardiol Therapeutics
CRDL
$90.4M
| $942K | 0.39% | 1,116,676 +471,219 | +73% | +$397K |
|
48
TherapeuticsMD
TXMD
$12.8M
| $904K | 0.38% | 401,937 +32,343 | +9% | +$72.8K |
|
49
Karyopharm Therapeutics
KPTI
$61.7M
| $892K | 0.37% | 1,031,348 -46,040 | -4% | -$39.8K |
|
50
Xperi
XPER
$278M
| $837K | 0.35% | 75,911 | – | – |
|